| 查看: 629 | 回复: 4 | |||
| 【奖励】 本帖被评价4次，作者fishhope增加金币 3.2 个 | |||
[资源]
《化学前沿》2012年4月（英文版）-THOMSON REUTERS
|
|||
|
IN THIS ISSUE 1 ORGA NIC SYNTHESIS SCHEME SHOWCASE In this report, we look at a breakthrough chemoenzymatic approach that shows promise for a more efficient route to synthesize ultra low molecular weight heparins. 4 SCAFFOLDS ON THE MOVE Dihydronaphthyridinediones could represent a novel structural class of potent and selective phosphodiesterase PDE7 inhibitors for the treatment of cognitive disorders. Also showcased are antimalarial agents, oncolytic drugs, and drugs to combat HIV. 8 NEW MOLECULAR MECHANISMS OF ACTION Hydroxyacid oxidase 2 (HAOX2, HAO2) inhibitors, integrin alphaMbeta2 (MAC-1) agonists and histone acetyltransferase (HAT) activators, among a range of fascinating compounds, are showcased in this issue. 9 THE START ING LINE A selection of new molecular entities ready to progress in the R&D arena including pharmacological activity, originator, and chemical structure. 12 NEW DRUGS FOR OLD The search for new drugs is an increasingly costly business. With patents expiring and pipelines drying up it is possible that the pharmaceutical industry is truly at the end of the so-called era of blockbusters. In this article, we look at how the industry is finding ways to reformulate and repurpose old products to new diseases and extracting novel applications for known agents. |
回复此楼» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : CuttingEdgeOfChemistry-2012-April.pdf
2014-02-27 07:52:23, 406.16 K
» 收录本帖的淘帖专辑推荐
 信息调研 |
» 猜你喜欢
谁有人卫版 《毒理学基础》第七版书籍
已经有0人回复
-
[求助] 流式死活染 & 单细胞门控设置被质疑，如何优化并解释？
已经有1人回复
-
药理学论文润色/翻译怎么收费?
已经有156人回复
-
蛋白稳定性实验与功能实验不一致
已经有11人回复
-
第4年了，马上40了，可能我与国基确实无缘吧。。。
已经有12人回复
-
关于SCI杂志发表挂名
已经有32人回复
-
26有没有老师想收做定量药理的学生啊
已经有3人回复
-
2026年申博药学专业
已经有1人回复
-
26考博申请 学or专
已经有15人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 【软件】Thomson Reuters EndNote X7 for Mac
已经有139人回复
- 【软件】Thomson Reuters EndNote X7 17.0.2.7390 参考文献管理软件
已经有306人回复
- 2013第三季度药业新观察（Thomson Reuters）以及2013年1-3季度的仿制药发展动态
已经有72人回复
- 请问thomson reuters 和SCI到底什么关系？这个杂志被SCI收录了吗？
已经有9人回复
- *** journal have been tracked for Impact Factors by Thomson Reuters(ISI)
已经有7人回复
2楼2014-02-27 08:24:36
简单回复
2014-02-27 08:33
回复
五星好评 顶一下，感谢分享！
kuanghua4楼
2014-03-01 08:54
回复
五星好评 顶一下，感谢分享！
200025045楼
2015-07-29 12:48
回复
五星好评 顶一下，感谢分享！